Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-09 3:24 pm Purchase | 2021-12-31 | 13G | Arrowhead Pharmaceuticals, Inc. ARWR | The Vanguard Group | 9,640,143 9.220% | 358,592 (+3.86%) | Filing History |
| 2022-01-27 11:00 am Unchanged | 2021-12-31 | 13G | Arrowhead Pharmaceuticals, Inc. ARWR | BlackRock Inc. BLK | 12,008,063 11.500% | 0 (Unchanged) | Filing History |
| 2022-01-25 3:03 pm Sale | 2021-12-31 | 13G | Arrowhead Pharmaceuticals, Inc. ARWR | BlackRock Inc. BLK | 12,008,063 11.500% | -555,069 (-4.42%) | Filing History |
| 2021-02-10 10:30 am Sale | 2020-12-31 | 13G | Arrowhead Pharmaceuticals, Inc. ARWR | The Vanguard Group | 9,281,551 9.030% | -515,956 (-5.27%) | Filing History |
| 2021-01-26 6:52 pm Purchase | 2020-12-31 | 13G | Arrowhead Pharmaceuticals, Inc. ARWR | BlackRock Inc. BLK | 12,563,132 12.200% | 202,174 (+1.64%) | Filing History |